LOS ANGELES, March 9, 2011 /PRNewswire/ -- Genesis Biopharma, Inc. (OTC Bulletin Board: GNBP), a biotechnology company developing targeted cancer therapies, today announced that Anthony Cataldo, President and Chief Executive Officer, and Marvin Hausman M.D., Chief Science Officer, will present to investors at the 23rd Annual Roth Capital Growth Stock Conference on Wednesday, March 16, 2011 at 2:00 p.m. Pacific. The conference is being held March 13-16 at the Ritz Carlton Hotel in Laguna Niguel, California.
A webcast of the presentation will be accessible online at www.genesis-biopharma.com. An archived version will be available for 30 days.
About Genesis Biopharma, Inc.
Genesis Biopharma, Inc. is a development-stage biotechnology company engaged in the development of targeted cancer therapies. For more information about the company, visit www.genesis-biopharma.com.
SOURCE Genesis Biopharma, Inc.